3 ms·

I'd actually be curious. Is it the type of thing where a vaccine ends it? Or will it be like the flu where it's always mutating and so the vaccine helps but it'

• sterlind 7y ago
  Not an expert, but creating a perennial vaccine depends on the mutation rate and which highly-conserved regions can be targeted. One of the potential vaccines enrolling trial patients is made of mRNA that codes for the spike protein needed for entry to cells. [0] If that spike protein turns out to be highly-conserved, then the vaccine will have sticking power. If it's not, but there turn out to be evolutionary trade-offs to adapting around it, it could push the virus to become less aggressive. 0. https://clinicaltrials.gov/ct2/show/NCT04283461 https://clinicaltrials.gov/ct2/show/NCT04283461